1 – In the past three months, how many metastatic hepatocellular carcinoma patients were treated with?
Sorafenib (Nexavar)
Other active systemic anti-cancer therapy
Other including palliative care
2 – In the past three months, how many metastatic renal cell carcinoma patients were treated with?
Sunitinib (Sutent)
Pazopanib (Votrient)
Everolimus (Afinitor)
Temsirolimus (Torisel)
Cabozantinib (Cometriq)
Nivolumab (Opdivo)
Axinitib (Inlyta)
Nivolumab + Ipilimumab (Opdivo + Yervoy)
Levantinib (Lenvima) + Everolimus (Afinitor)
Tivozanib (Fotivda)
Other active systemic anti-cancer therapy
Other including palliative care
3 – In the past 3 months, how many metastatic melanoma patients were treated with?
Pembrolizumab (Keytruda)
Nivolumab (Opdivo)
Ipilumumb (Yervoy)
Nivolumab + Ipilumumb (Opdivo + Yervoy)
Dabrafenib + Trametinib (Tafinlar + Mekinist)
Dabrafenib (Tafinlar)
Vemurafenib (Zelboraf)
Vemurafenib + cobimetinib (Zelboraf _ Cotellic)
Other active systemic anti-cancer therapy
Other including palliative care

Download response Metastatic hepatocellular carcinoma patients. 260418